Inhibition of a pathologic RBM39/MLL1 epigenomic regulatory complex with a dominant-negative peptides disrupts cancer cell transcription, proliferation and survival.
Ontology highlight
ABSTRACT: Inhibition of a pathologic RBM39/MLL1 epigenomic regulatory complex with a dominant-negative peptides disrupts cancer cell transcription, proliferation and survival.
PROVIDER: PRJNA603517 | ENA |
REPOSITORIES: ENA
ACCESS DATA